SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 573.51 |
| Enterprise Value ($M) | 499.22 |
| Book Value ($M) | 257.65 |
| Book Value / Share | 7.57 |
| Price / Book | 2.23 |
| NCAV ($M) | 209.69 |
| NCAV / Share | 6.16 |
| Price / NCAV | 2.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.14 |
| Current Ratio | 13.14 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 226.98 |
| Assets | 274.94 |
| Liabilities | 17.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -94.31 |
| Net Income | -80.49 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.21 |
| Cash from Investing | -192.47 |
| Cash from Financing | 186.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Suvretta Capital Management, Llc | 6.10 | ||
| 13G | Hillhouse Capital Advisors, Ltd. | 13.40 | ||
| 13G | Fmr Llc | 6.31 | ||
| 13G | Sofinnova Venture Partners XI, L.P. | 5.10 | ||
| 13G | BlackRock, Inc. | 5.80 | 0.00 | |
| 13G | Octagon Capital Advisors LP | 5.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 94,691 | 251,076 | 37.71 | |
| 81,645 | 206,383 | 39.56 | |
| 111,342 | 302,219 | 36.84 | |
| 106,512 | 256,493 | 41.53 | |
| 57,972 | 164,595 | 35.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATXS – Astria Therapeutics, Inc. | AUPH – Aurinia Pharmaceuticals Inc. |
| AURA – Aura Biosciences, Inc. | AVDL – Avadel Pharmaceuticals plc |
| AVTE – Aerovate Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io